$34.19
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
PTC Therapeutics
PTCTNASDAQ
PTC Therapeutics (NASDAQ:PTCT) Stock, Earnings Estimates, EPS, And Revenue
PTC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 1
EPS Estimate
$-1.050
Quarterly Revenue Estimate
$185.9M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$927.6M
Analyze the earnings history of PTC Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTCT | PTC Therapeutics | -$1.48 | -$1.05 | — | — | $213.81M | $185.87M | — | — | 08/01/2024 | Get Alert |
| PTCT | PTC Therapeutics | -$1.88 | -$1.24 | -$1.20 | 3.23% | $220.38M | $169.70M | $210.12M | 23.82% | 04/25/2024 | Get Alert |
| PTCT | PTC Therapeutics | -$1.89 | $0.50 | -$0.24 | -148.00% | $167.41M | $321.29M | $307.06M | -4.43% | 02/29/2024 | Get Alert |
| PTCT | PTC Therapeutics | -$1.53 | -$1.17 | -$1.76 | -50.43% | $217.13M | $210.19M | $196.58M | -6.48% | 10/26/2023 | Get Alert |
| PTCT | PTC Therapeutics | -$2.13 | -$1.58 | -$1.48 | 6.33% | $165.53M | $213.95M | $213.81M | -0.07% | 08/03/2023 | Get Alert |
| PTCT | PTC Therapeutics | -$1.78 | -$1.39 | -$1.88 | -35.25% | $148.74M | $182.62M | $220.38M | 20.68% | 04/27/2023 | Get Alert |
| PTCT | PTC Therapeutics | -$2.03 | -$1.59 | -$1.89 | -18.87% | $165.23M | $189.14M | $167.41M | -11.49% | 02/21/2023 | Get Alert |
| PTCT | PTC Therapeutics | -$1.89 | -$1.19 | -$1.53 | -28.57% | $138.74M | $186.90M | $217.13M | 16.17% | 10/27/2022 | Get Alert |
| PTCT | PTC Therapeutics | -$1.68 | -$1.33 | -$2.13 | -60.15% | $116.68M | $162.09M | $165.53M | 2.12% | 08/04/2022 | Get Alert |
| PTCT | PTC Therapeutics | -$1.83 | -$1.51 | -$1.78 | -17.88% | $117.94M | $147.06M | $148.74M | 1.14% | 05/03/2022 | Get Alert |
| PTCT | PTC Therapeutics | -$1.08 | -$1.64 | -$2.03 | -23.78% | $118.86M | $150.83M | $165.23M | 9.55% | 02/22/2022 | Get Alert |
| PTCT | PTC Therapeutics | -$1.03 | -$1.40 | -$1.89 | -35.00% | $118.40M | $126.44M | $138.74M | 9.73% | 10/28/2021 | Get Alert |
| PTCT | PTC Therapeutics | -$2.62 | -$1.82 | -$1.68 | 7.69% | $75.24M | $110.50M | $116.68M | 5.59% | 07/29/2021 | Get Alert |
| PTCT | PTC Therapeutics | -$1.81 | -$1.51 | -$1.83 | -21.19% | $68.26M | $98.80M | $117.94M | 19.37% | 05/04/2021 | Get Alert |
| PTCT | PTC Therapeutics | -$1.37 | -$0.94 | -$1.08 | -14.89% | $96.46M | $111.36M | $118.86M | 6.74% | 02/25/2021 | Get Alert |
| PTCT | PTC Therapeutics | -$1.06 | -$0.04 | -$1.03 | -2475.00% | $71.42M | $111.88M | $118.40M | 5.83% | 10/29/2020 | Get Alert |
| PTCT | PTC Therapeutics | -$0.75 | -$1.30 | -$2.62 | -101.54% | $85.52M | $82.78M | $75.24M | -9.11% | 08/05/2020 | Get Alert |
| PTCT | PTC Therapeutics | -$1.29 | -$1.31 | -$1.81 | -38.17% | $53.58M | $81.94M | $68.26M | -16.70% | 04/30/2020 | Get Alert |
| PTCT | PTC Therapeutics | -$0.58 | -$0.51 | -$1.37 | -168.63% | $86.34M | $95.24M | $96.46M | 1.28% | 03/02/2020 | Get Alert |
| PTCT | PTC Therapeutics | -$1.06 | -$0.76 | -$1.06 | -39.47% | $53.59M | $73.02M | $71.42M | -2.20% | 10/29/2019 | Get Alert |
| PTCT | PTC Therapeutics | -$0.21 | -$0.58 | -$0.75 | -29.31% | $68.74M | $78.64M | $85.52M | 8.75% | 08/06/2019 | Get Alert |
PTC Therapeutics (PTCT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-25 | $-1.20 | $-1.24 | 3.23 % |
| Dec 2023 | 2024-02-29 | $-0.24 | $0.50 | -148.0 % |
| Sep 2023 | 2023-10-26 | $-1.76 | $-1.17 | -50.4 % |
| Jun 2023 | 2023-08-03 | $-1.48 | $-1.58 | 6.33 % |
PTC Therapeutics (PTCT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-25 | $210.12M | $169.70M | 23.8 % |
| Dec 2023 | 2024-02-29 | $307.06M | $321.29M | -4.43 % |
| Sep 2023 | 2023-10-26 | $196.58M | $210.19M | -6.48 % |
| Jun 2023 | 2023-08-03 | $213.81M | $213.95M | -0.07 % |
FAQ
When is PTC Therapeutics (NASDAQ:PTCT) reporting earnings?
PTC Therapeutics (PTCT) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on April 25, 2024 for Q1.
What were the latest earnings per share (EPS) for PTC Therapeutics (NASDAQ:PTCT)?
The Actual EPS was $-1.20, which beat the estimate of $-1.24.
What were PTC Therapeutics’s (NASDAQ:PTCT) revenues?
The Actual Revenue was $210.1M, which beat the estimate of $169.7M.
Browse earnings estimates, EPS, and revenue on all stocks.